Adult patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis (mHLH)—a rare, aggressive hyperinflammatory condition—who were treated with the first-in-class monoclonal antibody, ELA026, ...
Dec 10, 2024
0
0
About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing form of lymphoma, will see their disease advance or recur following treatment. Seeking a new treatment strategy that might boost the effectiveness ...
Dec 10, 2024
0
1
For patients with haploidentical hematopoietic cell transplantation (haplo-HCT), the addition of itacitinib to standard graft versus host disease (GvHD) prophylaxis is well tolerated and results in low rates of cytokine release ...
Dec 10, 2024
0
0
Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers—follicular lymphoma and marginal zone lymphoma.
Dec 9, 2024
0
9
Helminths are known for their remarkable ability to regulate host immune responses, a trait that has intrigued scientists for its therapeutic potential. However, the mechanism behind this phenomenon has remained elusive. ...
Dec 9, 2024
0
6
Research from Duke-NUS Medical School has revealed that fetuses are not as defenseless as once thought; they can actually fight infections from within the womb. This new understanding could significantly change the way doctors ...
Dec 9, 2024
0
1
Patients with acute myeloid leukemia who have lower education levels and lower income are less likely to receive an allogeneic hematopoietic stem cell transplant for acute myeloid. However, if they can access the treatment, ...
Dec 9, 2024
0
0
A novel, fixed-duration drug combination—consisting of a second-generation BTK inhibitor, called acalabrutinib, plus a BCL-2 inhibitor (venetoclax), with or without a third blood cancer drug—shows deep and durable responses ...
Dec 9, 2024
0
0
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have reported results from the first-ever clinical trial demonstrating that a high-fiber, plant-based dietary intervention may delay progression to multiple myeloma, ...
Dec 8, 2024
0
69
A simple dietary supplement may provide a new approach to boost CAR T cell function, according to a study by researchers in the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer ...
Dec 7, 2024
0
64
